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Abstract: It is difficult to distinguish unexplained falls (UFs) from accidental falls (AFs) or 
syncope in older people. This study was designed to compare patients referred to the emergency 
department (ED) for AFs, UFs or syncope. Data from a longitudinal study on adverse drug 
events diagnosed at the ED (ANCESTRAL-ED) in older people were analyzed in order to 
select cases of AF, syncope, or UF. A total of 724 patients (median age: 81.0 [65–105] years, 
66.3% female) were consecutively admitted to the ED (403 AF, 210 syncope, and 111 UF). The 
number of psychotropic drugs was the only significant difference in patients with AF versus 
those with UF (odds ratio [OR] 1.44; 95% confidence interval 1.17–1.77). When comparing 
AF with syncope, female gender, musculoskeletal diseases, dementia, and systolic blood 
pressure 110 mmHg emerged as significantly associated with AF (OR 0.40 [0.27–0.58], 0.40 
[0.24–0.68], 0.35 [0.14–0.82], and 0.31 [0.20–0.49], respectively), while valvulopathy and the 
number of antihypertensive drugs were significantly related to syncope (OR 2.51 [1.07–5.90] 
and 1.24 [1.07–1.44], respectively). Upon comparison of UF and syncope, the number of cen-
tral nervous system drugs, female gender, musculoskeletal diseases, and SBP 110 mmHg 
were associated with UF (OR 0.65 [0.50–0.84], 0.52 [0.30–0.89], 0.40 [0.20–0.77], and 0.26 
[0.13–0.55]), respectively. These results indicate specific differences, in terms of demograph-
ics, medical/pharmacological history, and vital signs, among older patients admitted to the 
ED for AF and syncope. UF was associated with higher use of psychotropic drugs than AF. 
Our findings could be helpful in supporting a proper diagnostic process when evaluating older 
patients after a fall.
Keywords: older people, frailty, fall, accidental fall, syncope
Introduction
Falls represent a significant proportion of visits to the emergency department (ED) in 
the elderly.1,2 Some naturalistic studies showed that ~15% of ED admissions in older 
people are related to falls.1,3,4 The annual incidence of falls in community-dwelling 
subjects older than 65 years is ~28%–35%, up to 40% in those older than 75 years.5 
Forty percent of falls are due to accidental causes, while a substantial percentage remains 
unexplained,6 suggesting a possible overlap between the pathophysiology of falls and 
syncope.7,8 Interestingly, 20% of patients with syncope have amnesia for the loss of 
consciousness,9 and nearly two-thirds of older adults with orthostatic hypotension, who 
experience a fall, deny a loss of consciousness.10 Both accidental fall (AF) and syncope 
may cause traumatic injuries and are associated with poor global short- and long-term 
outcomes.11–13 Moreover, the economic burden of injuries due to AF or syncope repre-
sents one of the greatest sources of expenditure for traumatic patients.14,15
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In older people, AFs are generally related to an impaired 
physical performance and functional reserves and, in general, 
represent an epiphenomenon of the “frailty syndrome”.11 
By definition, syncope is a transient loss of consciousness 
caused by a transient reduction of global cerebral blood flow, 
whose diagnosis is mostly determined by a careful clinical 
history collection.16 A clear detection of the exact dynamic 
of the fall is quite challenging, especially in patients with 
moderate to severe amnestic cognitive impairment and 
several comorbidities (neurological, cardiac, and so on),14,17 
and in many cases, the underlying mechanism remains 
unexplained. Indeed, up to 30% of older people with unwit-
nessed syncope report AF rather than syncope.18 Moreover, 
in some cases, the pathophysiology of syncope (reduction 
of cerebral blood flow, eg, orthostatic hypotension) does 
not lead to a complete loss of consciousness but produces 
only transient-related symptoms, such as dizziness, vertigo, 
palpitation, and weakness, that may favor a fall.14,15 Like-
wise, similar prodromes may be due to vestibular disorders 
or psychotropic drug adverse effects.19 In order to provide 
proper therapeutic interventions, it is crucial to recognize the 
pathophysiology of falls, especially at the first-line evalua-
tion in the ED, where a misdiagnosis can adversely affect the 
long-term outcome.7,20 Given the difficulty of clearly distin-
guishing whether an unexplained fall (UF) in older people 
results from a syncope or accidental causes, we designed a 
clinical study to compare older patients (aged 65 years) 
consecutively admitted to the ED of the University Hospital 
of Pisa for syncope, AF, or UF. The patients were allocated 
to the AF group according to Tinetti et al21 criteria, and in 
order to clearly distinguish those patients from those who 
experienced an UF, we added the following criterion to this 
group: the absence of any prodrome (feeling of faint, palpi-
tation, vertigo, and dizziness) before falling. Patients who 
experienced falls without a complete loss of consciousness 
but with prodrome symptoms and/or amnesia for the event 
were allocated to the UF group. Patients were included in 
the syncope group according to the European Society of 
Cardiology Guideline on syncope.16
Patients and methods
This study is part of a larger prospective study on adverse drug 
reactions diagnosed at the ED of the University Hospital of Pisa 
(ANCESTRAL-ED).22 In detail, older patients (aged 65 years) 
referred to the ED were consecutively enrolled at the triage area 
by a team comprising of geriatricians and pharmacologists. 
Before any further study procedure, each enrolled patient gave 
written informed consent to partake in the study. In cases when 
patients were unable to provide consent, we took the informed 
consent from the legally authorized delegate. Each patient with 
mild to moderate medical problems (red code was excluded for 
impossibility in collecting the data due to the severity of cases) 
were interviewed. In the case of inability to properly answer 
questions, the informant was interviewed and the answers 
recorded in a database. A detailed medical (past and recent) and 
pharmacological history, along with vital signs and laboratory 
data (if  available), were collected. An online database (Microme-
dex®) was consulted to evaluate the expected drug reactions and 
possible drug–drug interactions. All the data were entered into a 
proper database. The Ethical Committee of the University Hos-
pital of Pisa approved the study protocol, which was designed 
in full accordance with the Declaration of Helsinki.
The enrolled patients were allocated to the AF group 
according to Tinetti et al:22
[…] an event which results in a person coming to rest 
unintentionally on the ground or other lower level, not 
as the result of a major intrinsic event (such as stroke) or 
overwhelming hazard. 
The absence of any prodrome (feeling of faint, palpitation, 
vertigo, and dizziness) before falling was added as further 
inclusion criterion. Patients were included in the syncope 
group according to the European Society of Cardiology 
Guideline on syncope:16
Syncope is a T-LOC due to transient global cerebral hypop-
erfusion characterized by rapid onset, short duration, and 
spontaneous complete recovery. 
Finally, patients who experienced falls without a complete 
loss of consciousness but with prodrome and/or amnesia 
for the event were allocated to the UF group. We excluded 
patients with presyncope symptoms without a fall or cases 
of uncertain dynamic (eg, patients with amnesia or unable to 
refer the dynamic of fall, without witnesses). Demographic 
data, past medical history, pharmacological information 
(number and class of drugs), laboratory data, and vital signs 
(heart rate, systolic blood pressure [SBP], diastolic blood 
pressure [DBP], peripheral oxygen saturation, and body 
temperature) were extracted from the ANCESTRAL-ED 
database. For each patient, we also took into consideration 
the presence of major chronic diseases, grouped in general 
classes (systemic hypertension, neurological disorders 
[chronic vascular encephalopathy, Parkinson’s disease, and 
other neurodegenerative disorders excluding dementia], any 
kind of dementia, cardiovascular diseases, musculoskeletal 
diseases [osteoporosis/sarcopenia with or without previous 
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fractures and osteoarthritis], anemia, and diabetes mellitus). 
The Cumulative Illness Rating Scale Severity (CIRS-S) and 
Cumulative Illness Rating Scale Comorbidity (CIRS-C)23 
were estimated for each patient.
statistical analysis
Statistical analysis was performed using SPSS Version 21 
(IBM Corporation, Armonk, NY, USA). Normally distrib-
uted variables were described as mean and standard devia-
tion (SD) and were compared across groups by independent 
t-test. Nonnormally distributed variables were described as 
median and range and compared using the Mann–Whitney 
U-test, while categorical variables were compared using the 
χ2 test. The Bonferroni correction was applied for multiple 
comparisons. Multiple logistic regression analysis (backward; 
probability for stepwise: 0.05 entry, 0.05 removal) with each 
clinically and statistically significant variable as covariates and 
the presence of AF/syncope, AF/UF, or syncope/UF as depen-
dent variables was performed. Age, the number of daily admin-
istered drugs, the number of daily antihypertensive drugs, and 
central nervous system (CNS) medications were considered as 
ordinal variables. For multivariate regression, missing values 
were imputed as values randomly extracted from the range of 
each specific parameter by Excel function (Microsoft©, Office). 
Bootstrapping analysis with 1,000 samples was also performed. 
Statistical significance was assigned for P0.05.
Results
We enrolled 724 patients (458 females, median age 81.0 
[range 65–105] years), 19.5% (95% confidence interval [CI] 
18.2–20.8) of the whole cohort of the ANCESTRAL-ED 
study: 403 patients with AF, 210 patients with syncope, 
and 111 patients with UF. Patients’ characteristics are 
reported in Table 1. Patients with syncope were significantly 
younger, with a higher prevalence of males than those with 
AF (P0.05 for both). The prevalence of musculoskeletal 
diseases was significantly higher in the AF and UF groups 
than in the syncope group (P0.05 for both).
Data on SBP and DBP were available for 587 patients (300 
patients with AF, 191 patients with syncope, and 96 patients 
with UF). The mean values of SBP and DBP (mmHg) were 
significantly lower in the syncope group with respect to 
both AF and UF groups (P0.05 for both). The median 
number of daily administered drugs was significantly higher 
in UF patients than in AF patients (5 vs 4 daily, P0.05), 
while those with syncope took more antihypertensive drugs 
than those with AF (P0.05). The daily use of CNS drugs 
was significantly greater in the UF group than either in the 
AF group or in the syncope group (P0.05 for both). The 
principal pharmacological classes of daily administered drugs 
are reported in Table 2. AF and syncope patients signifi-
cantly differed for the use of antihypertensive medications, 
particularly for angiotensin-converting enzyme inhibitors 
and angiotensin II receptor blockers (ACEIs–ARBs), alpha 
blockers, and diuretics (P0.05 for all). The use of nitrates 
was higher in the syncope group than in both the AF and 
UF groups (P0.05). The use of at least one psychotropic 
drug was significantly more frequent in patients with UF 
than in those with syncope (P0.05). A higher prevalence 
of UF patients was taking sedative/hypnotic or antiepileptic/
GABAergic drugs with respect to either AF patients or 
syncope patients (P0.05).
Multiregression analysis
The clinical parameters reported in Table 1 were analyzed by 
univariate regression analysis, comparing AFs vs UFs, AFs 
vs syncope, and syncope vs UFs. The results are reported 
in Table 1.
Multivariate regression analyses were performed select-
ing as independent variables those resulted significant in 
each univariate analysis of the above described compari-
sons. In order to simplify the comparison between groups, 
we transformed SBP values in a dichotomous variable by 
choosing the upper value of the first tertile as cutoff. By 
examining AF and syncope as dependent variables, the 
female gender, musculoskeletal diseases, dementia, and 
SBP 110 mmHg emerged as significantly associated with 
AF, while valvulopathy and the number of daily administered 
antihypertensive drugs were significantly related to syncope. 
By comparing UF and syncope, the number of daily admin-
istered CNS drugs, female gender, musculoskeletal diseases, 
and SBP 110 mmHg resulted as significantly associated 
with UFs. Finally, by comparing AFs and UFs, the number 
of CNS drugs emerged as the only significant parameter 
significantly associated with UFs (Table 3). As a sensitivity 
test, the bootstrapping method confirmed all the significances 
of the multiregression analysis.
Discussion
This study confirms that, in older adults, falls and syncope 
are striking health problems that account for approximately 
one-sixth of ED admissions of older people.1,2 Moreover, 
an accurate medical and pharmacological history along 
with SBP measurement, directly collected at the triage area, 
emerged as useful tools to identify the dynamic of the fall. 
Indeed, the presence of cardiac valvulopathy and the use of 
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elderly admitted to the emergency department for falls
antihypertensive medications resulted as potential risk factors 
for syncope, while female gender and SBP 110 mmHg, 
along with the presence of musculoskeletal diseases or 
dementia, characterized patients with AFs. These latter 
parameters were also associated with UFs compared to syn-
cope, while only a higher number of daily drugs, especially 
psychotropic, distinguished UFs from AFs.
UFs are variably defined in the literature, but none of 
the definitions clearly distinguishes between falls related to 
intrinsic causes affecting the postural tone, such as transient 
cerebral hypoperfusion or balance alterations, and those just 
caused by reduced physical performance, as observed in 
frail patients.24,25 In the current study, we have included all 
the patients who experienced amnesia and/or any prodrome 
before falling down in the UF group. Despite these premises, 
our results suggest that UFs and AFs may share a common 
pathophysiological process except for the use of drugs active 
on the CNS, favoring balance alteration.
In detail, we found a significant association between age 
and AFs as compared to syncope but not in case of UFs. It is 
well recognized that aging may act as a risk factor for both 
falls and syncope;16,26 however, it should be underlined that 
the overall patient cohort included a high number of oldest 
old people, characterized by frailty that leads to physical 
impairment. A higher prevalence of females among AFs 
and UFs as compared to an equivalent gender distribution in 
patients with syncope was also observed. The higher risk of 
falling, extensively reported in females, is generally ascribed 
to the higher prevalence of musculoskeletal diseases.27,28,44 
However, our data only partially support this hypothesis 
since, by multiregression analysis, both female gender and 
musculoskeletal diseases emerged as independent predictors 
of either AFs or UF as compared to syncope. Accordingly, no 
relationship has been reported between gender and syncope 
(including any causes) in older people.16
The history of dementia was significantly associated with 
both AFs and UFs in comparison to syncope. This finding is 
in line with a previous report that documented a greater risk 
of falling for patients with dementia.29 Nonetheless, given 
that dementia was three times more prevalent in patients with 
UF than in those with syncope, it should not be excluded 
that a proportion of patients with dementia could have suf-
fered from a syncope instead of an UF because of memory 
problems. However, if we look at the characteristics of 
each study group, patients with UF resulted more similar to 
those with AF than those with syncope. Moreover, dementia 
per se could act as a risk factor for falls as previously 
reported.24,29,42 Thus, the above described potential bias may 
only account for a small percentage of cases and marginally 
affect the results.
Another important clinical parameter strongly associ-
ated with both AFs and UFs in comparison to syncope 
was systemic blood pressure, either systolic or diastolic. 
Accordingly, ~90% of patients with AFs and UFs showed 
Table 2 Daily administered drugs in the three subgroups (accidental falls, syncope, and unexplained falls)
Drug type Accidental falls  
(n=403) (%)
Syncope  
(n=210) (%)
Unexplained falls 
(n=111) (%)
Total  
(N=724) (%)
Ah drugs 59.2a 70.3 64.2 63.2
ACeI–ArBs 34.8a 44 35.8 37.6
Ca-blocker DhP 11.9 11.5 15.6 12.4
Ca-blocker nDhP 5.0 2.9 5.5 4.4
Beta-blockers 1,742 24.9 16.5 19.4
Alpha blocker 6.2a 13.4 10.1 8.9
Diuretics 25.4a 36.8 30.3 29.4
nitrates 7.2a 13.4c 3.7 8.5
Antiarrhythmics 6.5 10.5 11.0 8.3
Digoxine 5.2 4.8 6.4 5.3
hypoglycemic agents 15.2 17.2 16.4 16.0
Psychotropic drugs 38.3 33.5c 50.0 38.4
Antihistamines 2.2 1.0 3.7 2.1
Anticholinergic 1.0 2.9 2.8 1.8
Antidepressive 21.4 14.4 24.8 19.9
sedative–hypnotic drugs 14.9b 12c 29.4 16.3
Antipsychotic 5.2 5.3 8.3 5.7
Antiepilectic/gABAergic 7.5b 7.2c 18.3 9.0
AChei 1.5 0.5 1.8 1.3
Notes: aAccidental falls vs syncope (P0.05, Bonferroni corrected). bAccidental falls vs unexplained falls (P0.05, Bonferroni corrected). csyncope vs unexplained falls 
(P0.05, Bonferroni corrected).
Abbreviations: ACEI–ARBs, angiotensin-converting enzyme inhibitor and angiotensin II receptor blockers; AChEi, acetylcholinesterase inhibitor; AH, antihypertensive; 
BDZ, benzodiazepine; DHP, dihydropyridine; NDHP, nondihydropyridine.
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elderly admitted to the emergency department for falls
SBP values 110 mmHg and one-third of those with syncope 
showed SBP values 110 mmHg. This finding is consistent 
with previous reports showing an excess use of antihyperten-
sive drugs in older patients with syncope.30,31,43 However, we 
found that the number of daily drugs was associated with syn-
cope and UFs with respect to AFs. Anyway, this parameter 
was removed from the multivariate analysis in all our com-
parisons, suggesting the presence of possible confounders 
such as the use of specific drug classes (psychotropics 
and antihypertensives). Indeed, we observed a significant 
association between syncope and alpha blockers, diuretics, 
or nitrates, while CNS drugs, especially sedative–hypnotic 
medications, were mainly associated with UFs. Interestingly, 
the number of CNS drugs was the most important factor that 
distinguishes AFs from UFs. These findings may suggest that 
most of the UFs are AFs caused by the detrimental effects 
of psychotropic drugs. The association between such drugs 
and falls or fall-related injuries has been extensively inves-
tigated, and several pharmacological mechanisms have been 
proposed.32 Of interest, van der Velde et al33 observed that 
the withdrawal of CNS drugs in patients at risk of fall may 
reduce the incidence of new events.
At multivariate analysis, the history of cardiac valvular 
disease was significantly associated with syncope when com-
pared with AFs. Accordingly, the presence of valvulopathy, 
particularly aortic stenosis, is a well-documented risk factor 
for syncope.34 The diagnosis of valvulopathy was done at the 
ED on the basis of the medical history; this circumstance 
may explain the relative small prevalence of valvulopathy 
with respect to that expected for the general population in 
western countries.34,35
Overall, our data suggest that an actual difference 
in terms of burden of comorbidity does not exist among 
elderly patients with different types of falls. This observa-
tion could be explained by a high proportion of very old 
people within each group of patients. Indeed, syncope is 
frequently associated with elderly comorbidities, such 
as heart disease (heart failure, structural heart diseases, 
and so on) and cerebrovascular and autonomic diseases 
(baroreceptor and vasovagal reflex alterations),16 while AFs 
usually result from decrements of muscle strength, vision, 
and vestibular reflex, which all are associated with the aging 
process36 and the so-called frailty syndrome.37,45 Since all 
the above mentioned comorbidities, usually associated with 
syncope, play a role also in the determinism of the frailty 
syndrome,38,39 frailty and clinical complexity may represent 
common phenotypes and could account for the overlap 
between syncope and falls.40
The large number of consecutively enrolled patients and 
the prospective design mainly represent the strength of this 
study. Nonetheless, some limitations should be properly taken 
into account while interpreting the results. We performed a 
naturalistic study examining only an ED population. Several 
missing values were present for laboratory data, and the 
analyses were cross-sectional without further analyses during 
follow-up. Our classification of pharmacological categories 
could differ from previous reports. We did not investigate 
the causes of syncope and did not perform a direct analysis 
of frailty (eg, gait speed and muscle strength).
Conclusion
Overall, the current data confirm the presence of perceptible 
clinical differences among older people who refer to ED for 
syncope or AF. Patients with UFs, frequently preceded by 
prodrome, show similar demographic and medical history 
as compared to those with AFs but take more psychotropic 
medications. These clinical differences should be taken into 
account for a proper diagnostic process and correct classifi-
cation as well as to possibly reduce the relapse rate. Future 
large, longitudinal studies aimed at evaluating the actual 
helpfulness of such factors in discriminating the cause of 
UF are warranted.
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